Status:
COMPLETED
Bergamot and Cardio-Metabolic Risk Factors
Lead Sponsor:
University of Palermo
Conditions:
Dyslipidemia
Eligibility:
All Genders
35-75 years
Brief Summary
Bergamot-derived products have shown significant effects on plasma lipids. We aim in the present study to evaluate the effect of bergamot on several cardio-metabolic risk markers.
Detailed Description
The research hypothesis is to assess whether bergamot reduces plasma lipids (total cholesterol, triglycerides, low-density lipoprotein (LDL)-cholesterol and high-density lipoprotein (HDL)-cholesterol)...
Eligibility Criteria
Inclusion
- elevated LDL-cholesterolemia
Exclusion
- severe hepatic or renal diseases
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT02205567
Start Date
June 1 2014
End Date
August 1 2015
Last Update
August 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Palermo
Palermo, PA, Italy, 90127